Samil, Boehringer Ingelheim sign exclusive distribution agreement over Mobic cap.

Published: 2009-03-19 06:59:00
Updated: 2009-03-19 06:59:00
Samil Pharm has signed an exclusive distribution agreement with Boeringer Ingelheim Korea to supply Mobic (meloxicma) in the domestic market.

“We are excited to enter into this collaboration with Boehringer Ingelheim, a research-driven pharmaceutical company,” a Samil official said.

“We bel...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.